Royal Bank of Canada’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $383K | Sell |
|
|||||
|
2025
Q2 | $1.79M | Buy |
|
|||||
|
2025
Q1 | $234K | Buy |
|
|||||
|
2024
Q4 | $17K | Sell |
|
|||||
|
2024
Q3 | $80K | Buy |
|
|||||
|
2024
Q2 | $41K | Buy |
|
|||||
|
2024
Q1 | $23K | Sell |
|
|||||
|
2023
Q4 | $44K | Buy |
|
|||||
|
2023
Q3 | $15K | Buy |
|
|||||
|
2023
Q2 | $24K | Buy |
|
|||||
|
2023
Q1 | $0 | Hold |
|
|||||
|
2022
Q4 | $0 | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $4K | Sell |
|
|||||
|
2021
Q4 | $28K | Buy |
|
|||||
|
2021
Q3 | $23K | Buy |
|
|||||
|
2021
Q2 | $31K | Sell |
|
|||||
|
2021
Q1 | $51K | Buy |
|